Journal of Jilin University(Medicine Edition) ›› 2025, Vol. 51 ›› Issue (3): 590-598.doi: 10.13481/j.1671-587X.20250304

• Research in basic medicine • Previous Articles    

Protective effect of sericin on streptozotocin-induced INS-1 cell damage by regulating PI3K/Akt/NF-κB signaling pathway through Akt1 and its mechanism

Cheng CHEN1,Jingyao LI2,Wanxiang HU3,Donghui LIU2(),Zhihong CHEN2()   

  1. 1.Department of Physiology,Collegle of Basic Medical Sciences,Chengde Medical College,Chengde 067000,China
    2.Department of Human Anatomy,Collegle of Basic Medical Sciences,Chengde Medical College,Chengde 067000,China
    3.Junkezhengyuan(Tianjin) Biopharmaceutical Technology Co. ,Ltd,Tianjin 301700,China
  • Received:2024-08-31 Accepted:2024-10-18 Online:2025-05-28 Published:2025-07-18
  • Contact: Donghui LIU,Zhihong CHEN E-mail:313804850@qq.com;czh1971@126.com

Abstract:

Objective To discuss the effect of sericin on the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/nuclear factor-κB (NF-κB) signaling pathway and apoptosis in the streptozotocin (STZ)-damaged INS-1 cells, and to clarify its mechanism. Methods The INS-1 cells were cultured with complete medium containing 0, 0.1, 0.3, 1.0, 3.0, and 10.0 μmol·L-1 Akt1 inhibitor A-674563, 10 mmol·L-1 STZ, and 600 mg·L-1 sericin, and divided into 0, 0.1, 0.3, 1.0, 3.0, and 10.0 μmol·L-1 A-674563 groups, and the control group (complete medium without drugs) was set up. Cell counting kit-8 (CCK-8) method was used to detect the survival rates of the INS-1 cells, and the half-maximal inhibitory concentration (IC50) value was calculated to determine the optimal inhibitory concentration of A-674563, which was further verified by Western blotting method. The INS-1 cells were divided into normal control group (complete medium), model group (10 mmol·L-1 STZ+complete medium), and low, medium, and high doses of sericin groups (10 mmol·L-1 STZ+150 mg·L-1 sericin+complete medium, 10 mmol·L-1 STZ+300 mg·L-1 sericin+complete medium, and 10 mmol·L-1 STZ+600 mg·L-1 sericin+complete medium). CCK-8 method was used to detect the survival rates of the INS-1 cells in various groups to determine the optimal concentration of sericin. Additionally, the INS-1 cells were divided into normal control group (complete medium), model group (10 mmol·L-1 STZ+complete medium), sericin group (10 mmol·L-1 STZ+600 mg·L-1 sericin + complete medium), and A-674563 group (10 mmol·L-1 STZ+600 mg·L-1 sericin+0.3 μmol·L-1 A-674563+complete medium). Flow cytometry was used to detect the apoptotic rates of the INS-1 cells in various groups; real-time fluorescence quantitative PCR (RT-qPCR ) method was used to detect the expression levels of Akt1, NF-κB, tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) mRNA in the INS-1 cells in various groups; Western blotting method was used to detect the expression levels of phosphorylated Akt1 (p-Akt1) and NF-κB proteins in the INS-1 cells in various groups; enzyme linked immunosorbent assay(ELISA) method was used to detect the levels of TNF-α and IL-6 in the INS-1 cells in various groups. Results The survival rates of the INS-1 cells in control group was 100.00%±0.00%; in 0, 0.1, 0.3, 1.0, 3.0, and 10.0 μmol·L-1 A-674563+10 mmol·L-1 STZ+600 mg·L-1 sericin+complete medium groups, which were 82.50%±2.28%, 69.47%±1.94%, 51.51%±1.74%, 38.94%±1.57%, 24.79%±1.14%, and 19.85%±1.03%, respectively. The IC?? value of A-674563 for INS-1 cells was 0.3 μmol·L-1, and 0.3 μmol·L-1 A-674563 was selected for subsequent experiments. Compared with 0 μmol·L-1 A-674563, the expression level of p-Akt1 protein in the INS-1 cells after treated with 0.3 μmol·L-1 A-674563+10 mmol·L-1 STZ + 600 mg·L-1 sericin+complete medium was significantly decreased (P<0.05). The CCK-8 results showed that compared with normal control group, the survival rate of the INS-1 cells in model group was significantly decreased (P<0.05); compared with model group, the survival rates of the INS-1 cells in low, medium, and high doses of sericin groups were significantly increased (P<0.05); compared with low and medium doses of sericin groups, the survival rate of the INS-1 cells in high dose of sericin group was significantly increased (P<0.05). Thus, 600 mg·L-1 sericin was selected for subsequent experiments. The CCK-8 results showed that compared with normal control group, the survival rate of the INS-1 cells in model group was significantly decreased (P<0.05); compared with model group, the survival rate of the INS-1 cells in sericin group was significantly increased (P<0.05); compared with sericin group, the survival rate of the INS-1 cells in A-674563 group was significantly decreased (P<0.05). The flow cytometry results showed that compared with normal control group, the apoptotic rate of the INS-1 cells in model group was significantly increased (P<0.05); compared with model group, the apoptotic rate of the INS-1 cells in sericin group was significantly decreased (P<0.05); compared with sericin group, the apoptotic rate of the INS-1 cells in A-674563 group was significantly increased (P<0.05). The RT-qPCR results showed that compared with normal control group, the expression level of Akt1 mRNA in the INS-1 cells in model group was significantly decreased (P<0.05); compared with model group, the expression levels of Akt1 mRNA in the INS-1 cells in low, medium, and high doses of sericin groups were significantly increased (P<0.05); compared with low and medium doses of sericin groups, the expression level of Akt1 mRNA in the INS-1 cells in high dose of sericin group was significantly increased (P<0.05). Compared with normal control group, the expression levels of NF-κB, TNF-α, and IL-6 mRNA in the INS-1 cells in model group were significantly increased (P<0.05); compared with model group, the expression levels of NF-κB, TNF-α, and IL-6 mRNA in the INS-1 cells in sericin group were significantly decreased (P<0.05); compared with sericin group, the expression level of NF-κB mRNA in the INS-1 cells in A-674563 group was significantly increased (P<0.05). The Western blotting results showed that compared with normal control group, the expression level of p-Akt1 protein in the INS-1 cells in model group was significantly decreased (P<0.05); compared with model group, the expression levels of p-Akt1 protein in the INS-1 cells in low, medium, and high doses of sericin groups were significantly increased (P<0.05); compared with low and medium doses of sericin groups, the expression level of p-Akt1 protein in the INS-1 cells in high dose of sericin group was significantly increased (P<0.05). Compared with normal control group, the expression level of NF-κB protein in the INS-1 cells in model group was significantly increased (P<0.05); compared with model group, the expression level of NF-κB protein in the INS-1 cells in sericin group was significantly decreased (P<0.05); compared with sericin group, the expression level of NF-κB protein in the INS-1 cells in A-674563 group was significantly increased (P<0.05). The ELISA results showed that compared with normal control group, the levels of TNF-α and IL-6 in the INS-1 cells in model group were significantly increased (P<0.05); compared with model group, the levels of TNF-α and IL-6 in the INS-1 cells in sericin group were significantly decreased (P<0.05); compared with sericin group, the levels of TNF-α and IL-6 in the INS-1 cells in A-674563 group were significantly increased (P<0.05). Conclusion Sericin alleviates the PI3K/Akt/NF-κB signaling pathway-mediated inflammatory response and apoptosis by targeting Akt1, exerting a protective effect against STZ-induced damage in INS-1 cells.

Key words: Sericin, INS-1 cells, Phosphatidylinositol 3-kinase/protein kinase B/nuclear factor-κB signaling pathway, Inflammatory response, Apoptosis

CLC Number: 

  • R587.1